These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21284437)

  • 1. Breast carcinoma in Uganda: microscopic study and receptor profile of 45 cases.
    Roy I; Othieno E
    Arch Pathol Lab Med; 2011 Feb; 135(2):194-9. PubMed ID: 21284437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of hormone receptors with Her-2 Neu protein expression and the histological grade in invasive breast cancers in a cohort of Saudi Arabia.
    Arafah M
    Turk Patoloji Derg; 2012; 28(1):38-43. PubMed ID: 22207430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential amplification and overexpression of HER-2/neu, p53, MIB1, and estrogen receptor/progesterone receptor among medullary carcinoma, atypical medullary carcinoma, and high-grade invasive ductal carcinoma of breast.
    Xu R; Feiner H; Li P; Yee H; Inghirami G; Delgado Y; Perle MA
    Arch Pathol Lab Med; 2003 Nov; 127(11):1458-64. PubMed ID: 14567723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological profile and receptor status in breast carcinoma: an institutional study.
    Rao C; Shetty J; Kishan Prasad HL
    J Cancer Res Ther; 2013; 9(1):44-9. PubMed ID: 23575073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype.
    Walter O; Prasad M; Lu S; Quinlan RM; Edmiston KL; Khan A
    Hum Pathol; 2009 Nov; 40(11):1528-33. PubMed ID: 19695680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cell-cycle regulatory proteins BUBR1, MAD2, Aurora A, cyclin A and cyclin E in invasive ductal breast carcinomas.
    Du J; Du Q; Zhang Y; Sajdik C; Ruan Y; Tian XX; Fang WG
    Histol Histopathol; 2011 Jun; 26(6):761-8. PubMed ID: 21472690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer.
    Hussein YR; Sood AK; Bandyopadhyay S; Albashiti B; Semaan A; Nahleh Z; Roh J; Han HD; Lopez-Berestein G; Ali-Fehmi R
    Hum Pathol; 2012 Oct; 43(10):1638-44. PubMed ID: 22436627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of estrogen receptor, progesterone receptor and HER2 results in concurrent ipsilateral samples with invasive breast carcinoma: a retrospective study of 246 biopsies from 119 patients.
    Singh K; Wang Y; Marketkar S; Kalife ET; Steinhoff MM
    Hum Pathol; 2017 Jul; 65():123-132. PubMed ID: 28457730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Her2/neu, estrogen and progesterone receptors in invasive micropapillary carcinoma of the breast.
    Kuroda H; Sakamoto G; Ohnisi K; Itoyama S
    Breast Cancer; 2004; 11(3):301-6. PubMed ID: 15550850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of androgen receptors in invasive breast carcinoma and its relation with estrogen receptor, progesterone receptor and Her2/neu expression.
    Alshenawy HA
    J Egypt Natl Canc Inst; 2012 Jun; 24(2):77-83. PubMed ID: 23582599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation.
    Niemeier LA; Dabbs DJ; Beriwal S; Striebel JM; Bhargava R
    Mod Pathol; 2010 Feb; 23(2):205-12. PubMed ID: 19898421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cyclooxygenase-2 and 12-lipoxygenase in human breast cancer and their relationship with HER-2/neu and hormonal receptors: impact on prognosis and therapy.
    Mohammad AM; Abdel HA; Abdel W; Ahmed AM; Wael T; Eiman G
    Indian J Cancer; 2006; 43(4):163-8. PubMed ID: 17192687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
    Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N
    Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical identification of basal-type cytokeratins in invasive ductal breast carcinoma--relation with grade, stage, estrogen receptor and HER2.
    Kusińska R; Potemski P; Jesionek-Kupnicka D; Kordek R
    Pol J Pathol; 2005; 56(3):107-10. PubMed ID: 16334976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtypes of Breast Cancer in Lao P.D.R.: A Study in a Limited-Resource Setting.
    Luangxay T; Virachith S; Hando K; Vilayvong S; Xaysomphet P; Arounlangsy P; Phongsavan K; Mieno MN; Honma N; Kitagawa M; Sawabe M
    Asian Pac J Cancer Prev; 2019 Feb; 20(2):589-594. PubMed ID: 30806064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical Expression of BRCA1 Protein, ER, PR and Her2/neu in Breast Cancer: A Clinicopathological Study.
    Hussein IA; Ahmed ST; Hameedi AD; Naji RZ; Alharbawi L; Alkhaytt M; Pity IS
    Asian Pac J Cancer Prev; 2020 Apr; 21(4):1025-1029. PubMed ID: 32334465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hormone receptors and HER2/neu in breast cancer cases in Jordan.
    Sughayer MA; Al-Khawaja MM; Massarweh S; Al-Masri M
    Pathol Oncol Res; 2006; 12(2):83-6. PubMed ID: 16799708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in intrinsic subtype of breast cancer during tumor progression in the same patient.
    Kim C; Lee J; Lee W; Kim A
    Int J Clin Exp Pathol; 2015; 8(11):15184-90. PubMed ID: 26823864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive Ductal Carcinoma: Correlation of Immunophenotypic Features with Age.
    Lateef F; Jamal S; Nasir S; Jamil Z
    J Coll Physicians Surg Pak; 2017 Jan; 27(1):18-22. PubMed ID: 28292362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.